-
Product Insights
NewNet Present Value Model: GSK plc’s AL-101
Empower your strategies with our Net Present Value Model: GSK plc's AL-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AL-002 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-002 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-002 in Alzheimer's Disease Drug Details: AL-002 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AL-8326 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-8326 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-8326 in Breast Cancer Drug Details: AL-8326 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AL-101 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-101 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-101 in Alzheimer's Disease Drug Details: AL-101 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AL-101 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-101 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-101 in Parkinson's Disease Drug Details: AL-101 is under development for the...
-
Product Insights
Al Sadawi Solar PV Project, Saudi Arabia
Al Sadawi Solar PV Project is proposed to be developed in Eastern Province, Saudi Arabia. Empower your strategies with our Al Sadawi Solar PV Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
Al Masa’a Solar PV Project, Saudi Arabia
Al Masa'a Solar PV Project is proposed to be developed in Ha'il, Saudi Arabia. Empower your strategies with our Al Masa'a Solar PV Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AL-8326 in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-8326 in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-8326 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: AL-8326 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AL-8326 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-8326 in Small-Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-8326 in Small-Cell Lung Cancer Drug Details: AL-8326 is under development...